News AZ failure cast further doubts over IL-13 drug asthma class AZ waits for second set of results due later this year.
News GSK’s Relvar Ellipta comes out on top in real world study Encouraging results will support growth of its next generation respiratory treatment
News Boosted by new drugs, Boehringer shrugs off patent expiry BI boosted by new diabetes and respiratory drugs.
News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
News Infex chases after Insmed with bronchiectasis trial win UK biotech Infex is in hot pursuit of Insmed's Brinsupri, the only approved therapy for non-CF bronchiectasis, with its quarterly-dosed antibody.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
